Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perfluorohexyloctane vs Sodium Hyaluronate for VDT-associated Dry Eye
NCT07679685Phase 4Not yet recruiting
- Sponsor
- Beijing Tongren Hospital
- Start
- Jun 2026
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
A Phase 4 trial of perfluorohexyloctane in dry eye syndrome (DED), sponsored by Beijing Tongren Hospital. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
perfluorohexyloctane
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT07679685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07679685.